BioBank
Association of Ukraine
services
Tissue Microarray Confinement

Recent developments in pathology research have lead to the invention of the tissue microarray. These innovations are paraffin blocks with up to 1000 tissue samples embedded in them at specific coordinates. The structure allows for high throughput analysis of multiple samples in parallel. Cylindrical tissue cores from a variety of donor blocks are assembled and embedded in a single block of paraffin at precise locations. Conditions are standardized on a single slide and facilitate the simultaneous analysis of DNA, RNA and proteins. Tissue samples are preserved and the best use of limited tissue archives is accomplished. Markers for diagnosis and prognostication of disease can be found using this new technique. Its automated workflow and data analysis supports retrospective and prospective tissue studies.

Services provide comprehensive clinical trial services in Eastern Europe (I-IV phases)

We support therapeutic antibody development through cross—reactivity testing in human tissue and other species (GLP & non—GLP). Regulatory work is carried out using the FDA, EMEA, and MAFF panels of normal tissues.

Our experience means we can also support immunotoxicity lymphocyte sub—group analysis, cell proliferation studies, and diagnostic research services, as well as target validation and clinical biomarker assays.

  • Tissue samples or biopsies
  • Blood and bio—fluids
  • Cells
  • FFPE samples
Custom collection Services

We support therapeutic antibody development through cross—reactivity testing in human tissue and other species (GLP & non—GLP). Regulatory work is carried out using the FDA, EMEA, and MAFF panels of normal tissues.

Our experience means we can also support immunotoxicity lymphocyte sub—group analysis, cell proliferation studies, and diagnostic research services, as well as target validation and clinical biomarker assays.

  • Tissue samples or biopsies
  • Blood and bio—fluids
  • Cells
  • FFPE samples
Section of Oncology and Clinical Research Laboratory

We support therapeutic antibody development through cross—reactivity testing in human tissue and other species (GLP & non—GLP). Regulatory work is carried out using the FDA, EMEA, and MAFF panels of normal tissues.

Our experience means we can also support immunotoxicity lymphocyte sub—group analysis, cell proliferation studies, and diagnostic research services, as well as target validation and clinical biomarker assays.

  • Tissue samples or biopsies
  • Blood and bio—fluids
  • Cells
  • FFPE samples
Our team
contacts
Lermontovska str. 26,
Kharkiv 61000
Ukraine
Phone:
Email:
Folow us:
Contact us: